BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19251827)

  • 1. Nicotinic receptors and stages of nicotine dependence.
    Brennan KA; Lea RA; Fitzmaurice PS; Truman P
    J Psychopharmacol; 2010 Jun; 24(6):793-808. PubMed ID: 19251827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco addiction: a biochemical model of nicotine dependence.
    Ortells MO; Barrantes GE
    Med Hypotheses; 2010 May; 74(5):884-94. PubMed ID: 19962246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery.
    Papke RL; Dwoskin LP; Crooks PA
    J Neurochem; 2007 Apr; 101(1):160-7. PubMed ID: 17241116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal networks of nicotine addiction.
    Ortells MO; Arias HR
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1931-5. PubMed ID: 20833261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular mechanisms of action of nicotine in the CNS.
    Barik J; Wonnacott S
    Handb Exp Pharmacol; 2009; (192):173-207. PubMed ID: 19184650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine: from molecular mechanisms to behaviour.
    Wonnacott S; Sidhpura N; Balfour DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):53-9. PubMed ID: 15661626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nicotine dependence].
    Lebargy F
    Rev Pneumol Clin; 2000 Jun; 56(3):177-83. PubMed ID: 10880944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nicotine dependence--medico-biological aspects].
    Dybing E; Sanner T
    Tidsskr Nor Laegeforen; 2002 Jan; 122(3):302-5. PubMed ID: 11894603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions.
    Greenbaum L; Lerer B
    Mol Psychiatry; 2009 Oct; 14(10):912-45. PubMed ID: 19564872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.
    Crooks PA; Ayers JT; Xu R; Sumithran SP; Grinevich VP; Wilkins LH; Deaciuc AG; Allen DD; Dwoskin LP
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1869-74. PubMed ID: 15050618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking kills (alcoholics)! shouldn't we do something about it?
    Littleton J; Barron S; Prendergast M; Nixon SJ
    Alcohol Alcohol; 2007; 42(3):167-73. PubMed ID: 17526626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiology of nicotine addiction: implications for smoking cessation treatment.
    Benowitz NL
    Am J Med; 2008 Apr; 121(4 Suppl 1):S3-10. PubMed ID: 18342164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nicotine dependence and its molecular pharmacology].
    Yoshimura R; Nakamura J
    Nihon Rinsho; 2013 Mar; 71(3):473-6. PubMed ID: 23631238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine addiction: the possible role of functional upregulation.
    Buisson B; Bertrand D
    Trends Pharmacol Sci; 2002 Mar; 23(3):130-6. PubMed ID: 11879680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.
    Wittenberg RE; Wolfman SL; De Biasi M; Dani JA
    Neuropharmacology; 2020 Oct; 177():108256. PubMed ID: 32738308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional diversity of native brain neuronal nicotinic receptors.
    Gotti C; Clementi F; Fornari A; Gaimarri A; Guiducci S; Manfredi I; Moretti M; Pedrazzi P; Pucci L; Zoli M
    Biochem Pharmacol; 2009 Oct; 78(7):703-11. PubMed ID: 19481063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
    Rollema H; Coe JW; Chambers LK; Hurst RS; Stahl SM; Williams KE
    Trends Pharmacol Sci; 2007 Jul; 28(7):316-25. PubMed ID: 17573127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New mechanisms and perspectives in nicotine withdrawal.
    Jackson KJ; Muldoon PP; De Biasi M; Damaj MI
    Neuropharmacology; 2015 Sep; 96(Pt B):223-34. PubMed ID: 25433149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
    Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase and tobacco dependence.
    Lewis A; Miller JH; Lea RA
    Neurotoxicology; 2007 Jan; 28(1):182-95. PubMed ID: 16859748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.